Quest Diagnostics (DGX) Shares Outstanding (2009 - 2026)

Quest Diagnostics has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $110.4 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 1.3% year-over-year to $110.4 million; the TTM figure through Jun 2026 stood at $110.4 million (down 1.3% YoY), while the FY2025 annual figure was $109.9 million, down 1.0% from the prior year.
• Shares Outstanding (Entity) came in at $110.4 million for Q2 2026 at Quest Diagnostics, roughly flat from $110.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $117.4 million in Q1 2022 to a low of $109.9 million in Q4 2025.
• Average Shares Outstanding (Entity) over 5 years is $112.1 million, with a median of $111.5 million recorded in 2022.
• Year-over-year, Shares Outstanding (Entity) decreased 10.16% in 2022 and climbed 0.49% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $111.3 million in 2022, then declined by 0.55% to $110.7 million in 2023, then advanced by 0.24% to $111.0 million in 2024, then retreated by 1.0% to $109.9 million in 2025, then advanced by 0.46% to $110.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $110.4 million in Q2 2026, $110.7 million in Q1 2026, and $109.9 million in Q4 2025.